Cross Country Healthcare, Inc.

NASDAQ:CCRN

Medical - Care Facilities

Healthcare
$13.25 +0.08%

+$0.01 today

Market cap
$428.06M
Beta
0.45
P/E (TTM)
-4.2
EPS (TTM)
-$3.13
52W Low $7.43High $14.99

Volume 1.78M

Average 0.64M

CCRN Common Stock Repurchased

Cash spent buying back the company's own shares.

Cross Country Healthcare, Inc.NASDAQ: CCRN

Common Stock Repurchased · Q1 FY2026 · quarter ended Mar 2026

Common stock repurchased growth accelerates

Q1 FY2026 common stock repurchased of $5.87M (cash outflow) rose 1768.8% year over year, ahead of the -54.7% change in trailing-twelve-month common stock repurchased. Sequentially, it fell 10.0% from the prior quarter. Over 3 fiscal years it compounded at -42.1% a year.

Context

  • Common stock repurchased amounted to 0.6% of revenue in FY2025, down 2.1 pp from a year earlier.
  • Common stock repurchased grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1768.8% holds above the trailing-twelve-month pace of -54.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$5.87M-10.0% QoQ
Last fiscal yearDec 2025
-$6.83M-81.7% YoY
LTMMar 2026
-$14.15M-54.7% YoY
Common Stock Repurchased past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1768.8%——
1 year-81.7%——
3-year CAGR-42.1%——
5-year CAGR——
10-year CAGR——

Common Stock Repurchased history

USD · from the cash flow

Latest · FY2025
(6.83M) USD
Year-over-year change
+81.7%

Common Stock Repurchased vs competitors

How CCRN compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock repurchased is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -54.7% is the 2nd highest of 3, against a peer median of +796.6%.
  • Common stock repurchased amounts to 1.4% of revenue for CCRN, versus a peer median of 0.0%.
CCRN Competitors
Common Stock Repurchased for CCRN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CCRNCross Country Healthcare, Inc.LTM Mar 2026$14.15M USD-54.7%-42.1%1.4%
AGLAgilon Health, Inc.LTM Mar 2026$2.87M USD+1681.4%—0.0%
OPRXOptimizeRx CorporationLTM Mar 2026$101K USD-88.2%—0.1%
SNDASonida Senior Living, Inc.LTM Mar 2026$0 USD——0.0%
TOIThe Oncology Institute, Inc.LTM Mar 2026$0 USD——0.0%
KIDSOrthoPediatrics Corp.LTM Mar 2026$0 USD——0.0%
MCTACharming Medical Limited Class A Ordinary SharesFY2024$0 USD——0.0%
AUNAAuna S.A.LTM Mar 2026PEN 0 PEN——0.0%
TMCITreace Medical Concepts, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding CCRN) —+796.6%—0.0%

Competitors are the stored peer set for CCRN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income132M185.98M72.63M(14.56M)(94.85M)
Depreciation & Amortization9.85M12.58M18.35M18.2M16.79M
Deferred Income Tax(9.93M)5.11M1.3M(1.94M)10.07M
Stock-Based Compensation6.89M7.39M6.58M6.03M7.14M
Change in Working Capital(237.26M)(103.71M)127.48M87.63M30.47M
Accounts Receivables(318.42M)(153.23M)251.43M128.33M56.73M
Inventory(83.29M)0000
Accounts Payables83.29M0(126.61M)(29.75M)0
Other Working Capital81.16M49.52M2.66M(10.95M)(26.26M)
Other Non-Cash Items12.82M26.7M22.16M24.77M78.63M
Operating Cash Flow(85.62M)134.05M248.5M120.12M48.25M
Capital Expenditures(7.17M)(8.79M)(13.97M)(8.71M)(8.16M)
Acquisitions (Net)(26.88M)(35.09M)199K00
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow(34.05M)(43.87M)(13.78M)(8.71M)(8.16M)
Debt Repayment127.68M32.34M(150.68M)00
Common Stock Issued00000
Common Stock Repurchased(2.23M)(35.29M)(57.65M)(37.31M)(6.83M)
Dividends Paid00000
Other Financing Activities(6.35M)(84.65M)(12.91M)(9.54M)(6.17M)
Financing Cash Flow119.09M(87.6M)(221.24M)(46.85M)(13.01M)
Effect of Forex Changes6K(9K)8K(14K)21K
Net Change in Cash(564K)2.57M13.49M64.54M27.11M
Free Cash Flow(92.79M)125.26M234.52M111.4M40.09M

Cross Country Healthcare, Inc.

NASDAQ:CCRN

Intrinsic Alpha fair value

Locked

Current Price

$13.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.